Maxacalcitol intravenous injection for dialysis 5μg “Towa”, manufactured by Towa Pharmaceutical, contains Maxacalcitol. This injectable vitamin D3 analog is used for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis. It has a YJ code of 3112401A2073 and a standard of 5 μg 1 mL 1 tube.
Maxacalcitol intravenous injection for dialysis 5μg “Towa”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →